... He's chief medical officer for TaiMed Biologics, maker of the drug and sponsor of the trial."HIV is probably the most dynamic pathogen in medicine. It's been a challenge to stay one step ahead of it," Lewis said.The new drug is called a monoclonal antibody. It works by binding to receptors on CD4 cells. ...
New Drug of Last Resort Tackles Resistant HIV
... He's chief medical officer for TaiMed Biologics, maker of the drug and sponsor of the trial."HIV is probably the most dynamic pathogen in medicine. It's been a challenge to stay one step ahead of it," Lewis said.The new drug is called a monoclonal antibody. It works by binding to receptors on CD4 cells. ...